Evidence map›Paper›PMID 29387258›Full record

ArticleAnnals of thoracic medicine

Description of a new rare alpha-1 antitrypsin mutation in Naples (Italy): PI*M S-Napoli.

Marco Mosella, Mariasofia Accardo, Antonio Molino, Mauro Maniscalco, Alessandro Sanduzzi Zamparelli

Open access · diamondAbstract readCase Reports
In one paragraph

Article in Annals of thoracic medicine. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.5field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Alpha-1 antitrypsin deficiency associated with rareRespiratory medicine case reports · 2024
    Article
  2. Article
  3. Alpha-1-Antitrypsin Deficiency and Bronchiectasis: A Concomitance or a Real Association?International journal of environmental research and public health · 2020
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Marco MosellaDepartment of Clinical Medicine and Surgery, Federico II University Hospital, Naples, Italy.
Mariasofia AccardoDepartment of Clinical Medicine and Surgery, Federico II University Hospital, Naples, Italy.
Antonio MolinoDepartment of Respiratory Diseases, Division of Pneumology, University of Naples Federico II, AORN dei Colli-Monaldi Hospital, Naples, Italy.
Mauro ManiscalcoDepartment of Cardio- Respiratory Rehabilitation, Pulmonary Rehabilitation Unit, ICS Maugeri SpA SB, Institute of Telese Terme, Benevento, Italy.
Alessandro Sanduzzi ZamparelliDepartment of Clinical Medicine and Surgery, Federico II University Hospital, Naples, Italy.
Federico II University Hospital · ITIstituti Clinici Scientifici Maugeri · ITUniversity of Naples Federico II · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Alpha-1 antitrypsin deficiency is a rare and often underdiagnosed hereditary disorder, which mainly affects the Caucasian population. We report a case of a noncystic fibrosis bronchiectasis patient in the absence of emphysema associated with low serum alpha-1-antitrypsin (AAT) level, in the absence of the most common defective alleles associated with AAT deficiency (PI*S and PI*Z) but with a new mutation in heterozygosis. This mutation is characterized by the substitution in the coding region of exon 3, of a guanine (G) for a thymine (T), generating the replacement of a glutamine (Gln) by a histidine (His) in codon 212 (cod 212 GlnCAG > HisCAT), corresponds to a new S allelic variant. This mutation, never identified before, is called S-Napoli.

Indexed as

Alpha-1 antitrypsin deficiencybronchiectasisemphysema

Identifiers

PMID29387258
PMCPMC5772110
OpenAlexW2785719763

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.